{"id":52478,"date":"2023-01-03T17:02:08","date_gmt":"2023-01-03T16:02:08","guid":{"rendered":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/"},"modified":"2023-01-03T17:02:08","modified_gmt":"2023-01-03T16:02:08","slug":"global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com","status":"publish","type":"post","link":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/","title":{"rendered":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts &#8211; ResearchAndMarkets.com"},"content":{"rendered":"<div>\n<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656417\/oncology-biosimilars-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7l5kbz&amp;utm_campaign=1801445+-+Global+Oncology+Biosimilars+Market+Report+2022+to+2027%3A+Industry+Trends%2C+Share%2C+Size%2C+Growth%2C+Opportunities+and+Forecasts&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">&#8220;Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221;<\/a> report has been added to <strong>ResearchAndMarkets.com&#8217;s<\/strong> offering.\n<\/p>\n<p><a href=\"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/4\/logo.jpg\"><img decoding=\"async\" src=\"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg\"><\/a><\/p>\n<p>\nThe global oncology biosimilars market size reached US$ 2.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12 Billion by 2027, exhibiting a CAGR of 26.71% during 2021-2027.\n<\/p>\n<p>\n<strong>Companies Mentioned<\/strong>\n<\/p>\n<ul>\n<li>\nBiocon Limited\n<\/li>\n<li>\nCelltrion Inc.\n<\/li>\n<li>\nDr. Reddy&#8217;s Laboratories Ltd.\n<\/li>\n<li>\nIntas Pharmaceuticals Ltd.\n<\/li>\n<li>\nSTADA Arzneimittel AG\n<\/li>\n<li>\nPfizer Inc.\n<\/li>\n<li>\nApotex Inc.\n<\/li>\n<li>\nTeva Pharmaceutical Industries Ltd.\n<\/li>\n<li>\nSandoz International GmbH\n<\/li>\n<li>\nBIOCAD Biotechnology Company\n<\/li>\n<li>\nMylan N.V.\n<\/li>\n<li>\nF. Hoffmann-La Roche AG\n<\/li>\n<\/ul>\n<p>\nKeeping in mind the uncertainties of COVID-19, we are continuously tracking and evaluating the direct as well as the indirect influence of the pandemic. These insights are included in the report as a major market contributor.\n<\/p>\n<p>\nCancer is a lifestyle disease that occurs due to the abnormal growth of cells and may result in the formation of a tumor. At present, most of the effective cancer treatments are based on biological drugs, also known as biologics, and include targeted therapies as well as immunotherapies.\n<\/p>\n<p>\nThese drugs are produced using living organisms, including bacteria, yeast, and animal or plant cells, and require complex manufacturing processes and long development time. As a result, the cost of these drugs is relatively higher, which adds to the expense of cancer treatment.\n<\/p>\n<p>\nTo lower the price of treatment, the interest in the development of biosimilars of branded oncology biologics has been increasing. These biosimilars are highly similar to the reference biologics in terms of effectiveness and safety and can help in significantly reducing the expenditure on cancer treatment due to their lower cost.\n<\/p>\n<p>\nOver the years, the rising number of geriatric population and environmental degradation have increased the prevalence of cancer across the globe. These factors, along with the inflating cost of cancer care, have increased the burden on healthcare systems worldwide. Consequently, governing authorities in numerous countries are promoting the uptake of biosimilars as a cost-containment measure.\n<\/p>\n<p>\nFor instance, the United States Food and Drug Administration (USFDA) has developed information materials for physicians and patients to educate them about biosimilars. Apart from this, the availability of affordable medication has also been associated with earlier and wider therapy use as well as improved patient access.\n<\/p>\n<p>\nBesides this, oncology biosimilars can also increase industry competition, owing to which they have the potential to drive down the prices of biological drugs further. Some of the other growth-inducing factors for the market include approaching patent expiries of branded biologics and increasing research and development (R&amp;D) activities by biosimilar manufacturers.\n<\/p>\n<p>\n<strong>Key Market Segmentation:<\/strong>\n<\/p>\n<p>\nThe publisher provides an analysis of the key trends in each sub-segment of the global oncology biosimilars market report, along with forecasts at the global and regional level from 2022-2027. Our report has categorized the market based on drug type, cancer type and distribution channel.\n<\/p>\n<p>\n<strong>Breakup by Drug Type:<\/strong>\n<\/p>\n<ul>\n<li>\nMonoclonal Antibody\n<\/li>\n<li>\nImmunomodulators\n<\/li>\n<li>\nG-CSF\n<\/li>\n<li>\nHematopoietic Agents\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Cancer Type:<\/strong>\n<\/p>\n<ul>\n<li>\nLung Cancer\n<\/li>\n<li>\nColorectal Cancer\n<\/li>\n<li>\nCervical Cancer\n<\/li>\n<li>\nBreast Cancer\n<\/li>\n<li>\nKidney Cancer\n<\/li>\n<li>\nStomach Cancer\n<\/li>\n<li>\nBrain Cancer\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Distribution Channel:<\/strong>\n<\/p>\n<ul>\n<li>\nHospital Pharmacies\n<\/li>\n<li>\nOnline Pharmacies\n<\/li>\n<li>\nRetail Pharmacies\n<\/li>\n<li>\nOthers\n<\/li>\n<\/ul>\n<p>\n<strong>Breakup by Region:<\/strong>\n<\/p>\n<ul>\n<li>\nEurope\n<\/li>\n<li>\nAsia Pacific\n<\/li>\n<li>\nNorth America\n<\/li>\n<li>\nMiddle East and Africa\n<\/li>\n<li>\nLatin America\n<\/li>\n<\/ul>\n<p>\n<strong>Key Questions Answered in This Report:<\/strong>\n<\/p>\n<ul>\n<li>\nHow has the global oncology biosimilars market performed so far and how will it perform in the coming years?\n<\/li>\n<li>\nWhat has been the impact of COVID-19 on the global oncology biosimilars industry?\n<\/li>\n<li>\nWhat are the key regional markets in the global oncology biosimilars industry?\n<\/li>\n<li>\nWhat is the breakup of the market based on the drug type?\n<\/li>\n<li>\nWhat is the breakup of the market based on the cancer type?\n<\/li>\n<li>\nWhat is the breakup of the market based on the distribution channel?\n<\/li>\n<li>\nWhat are the various stages in the value chain of the global oncology biosimilars industry?\n<\/li>\n<li>\nWhat are the key driving factors and challenges in the global oncology biosimilars industry?\n<\/li>\n<li>\nWhat is the structure of the global oncology biosimilars industry and who are the key players?\n<\/li>\n<li>\nWhat is the degree of competition in the global oncology biosimilars industry?\n<\/li>\n<\/ul>\n<p>\nFor more information about this report visit <a target=\"_blank\" href=\"https:\/\/www.researchandmarkets.com\/reports\/5656417\/oncology-biosimilars-market-global-industry?utm_source=BW&amp;utm_medium=PressRelease&amp;utm_code=7l5kbz&amp;utm_campaign=1801445+-+Global+Oncology+Biosimilars+Market+Report+2022+to+2027%3A+Industry+Trends%2C+Share%2C+Size%2C+Growth%2C+Opportunities+and+Forecasts&amp;utm_exec=jamu273prd\" rel=\"nofollow noopener\" shape=\"rect\">https:\/\/www.researchandmarkets.com\/r\/dudi9p<\/a>\n<\/p>\n<p> <b>Contacts<\/b> <\/p>\n<p>\nResearchAndMarkets.com<br \/>\n<br \/>Laura Wood, Senior Press Manager<br \/>\n<br \/><a target=\"_blank\" href=\"&#109;&#x61;&#x69;l&#116;&#x6f;&#x3a;p&#114;&#x65;s&#115;&#x40;&#x72;e&#115;&#x65;a&#114;&#x63;&#x68;a&#110;&#x64;&#x6d;&#97;&#x72;&#x6b;e&#116;&#x73;&#x2e;c&#111;&#x6d;\" rel=\"nofollow noopener\" shape=\"rect\">pre&#115;&#115;&#64;&#x72;&#x65;&#x73;&#x65;&#x61;&#x72;cha&#110;&#100;&#109;&#97;&#x72;&#x6b;&#x65;&#x74;&#x73;&#x2e;com<\/a><br \/>For E.S.T Office Hours Call 1-917-300-0470<br \/>\n<br \/>For U.S.\/ CAN Toll Free Call 1-800-526-8630<br \/>\n<br \/>For GMT Office Hours Call +353-1-416-8900\n<\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology biosimilars market size reached US$ 2.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12 Billion by 2027, exhibiting a CAGR of 26.71% during 2021-2027. &#8230; <span class=\"more\"><a class=\"more-link\" href=\"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/\">[Read more&#8230;]<\/a><\/span><\/p>\n","protected":false},"author":4,"featured_media":0,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"footnotes":""},"categories":[13],"tags":[],"class_list":{"0":"entry","1":"post","2":"publish","3":"author-business","4":"post-52478","6":"format-standard","7":"category-industry"},"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.3 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/\" \/>\n<meta property=\"og:locale\" content=\"en_US\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend\" \/>\n<meta property=\"og:description\" content=\"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology biosimilars market size reached US$ 2.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12 Billion by 2027, exhibiting a CAGR of 26.71% during 2021-2027. ... [Read more...]\" \/>\n<meta property=\"og:url\" content=\"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/\" \/>\n<meta property=\"og:site_name\" content=\"Pharma Trend\" \/>\n<meta property=\"article:published_time\" content=\"2023-01-03T16:02:08+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg\" \/>\n<meta name=\"author\" content=\"Business Wire\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Business Wire\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"4 minutes\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/\"},\"author\":{\"name\":\"Business Wire\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\"},\"headline\":\"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts &#8211; ResearchAndMarkets.com\",\"datePublished\":\"2023-01-03T16:02:08+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/\"},\"wordCount\":741,\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005566\\\/en\\\/1675341\\\/21\\\/logo.jpg\",\"articleSection\":[\"Industry\"],\"inLanguage\":\"en-US\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/\",\"name\":\"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005566\\\/en\\\/1675341\\\/21\\\/logo.jpg\",\"datePublished\":\"2023-01-03T16:02:08+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#breadcrumb\"},\"inLanguage\":\"en-US\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#primaryimage\",\"url\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005566\\\/en\\\/1675341\\\/21\\\/logo.jpg\",\"contentUrl\":\"https:\\\/\\\/mms.businesswire.com\\\/media\\\/20230103005566\\\/en\\\/1675341\\\/21\\\/logo.jpg\"},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Startseite\",\"item\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts &#8211; ResearchAndMarkets.com\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#website\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"name\":\"Pharma Trend\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"en-US\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#organization\",\"name\":\"Pharma Trend\",\"url\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"en-US\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"\",\"contentUrl\":\"\",\"caption\":\"Pharma Trend\"},\"image\":{\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/logo\\\/image\\\/\"}},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/pharma-trend.com\\\/en\\\/#\\\/schema\\\/person\\\/02d41342c7a74fa7f0032bb35ef0bb24\",\"name\":\"Business Wire\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/","og_locale":"en_US","og_type":"article","og_title":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend","og_description":"DUBLIN&#8211;(BUSINESS WIRE)&#8211;The &#8220;Oncology Biosimilars Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2022-2027&#8221; report has been added to ResearchAndMarkets.com&#8217;s offering. The global oncology biosimilars market size reached US$ 2.9 Billion in 2021. Looking forward, the publisher expects the market to reach US$ 12 Billion by 2027, exhibiting a CAGR of 26.71% during 2021-2027. ... [Read more...]","og_url":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/","og_site_name":"Pharma Trend","article_published_time":"2023-01-03T16:02:08+00:00","og_image":[{"url":"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg","type":"","width":"","height":""}],"author":"Business Wire","twitter_card":"summary_large_image","twitter_misc":{"Written by":"Business Wire","Est. reading time":"4 minutes"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#article","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/"},"author":{"name":"Business Wire","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24"},"headline":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts &#8211; ResearchAndMarkets.com","datePublished":"2023-01-03T16:02:08+00:00","mainEntityOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/"},"wordCount":741,"publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg","articleSection":["Industry"],"inLanguage":"en-US"},{"@type":"WebPage","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/","url":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/","name":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts - ResearchAndMarkets.com - Pharma Trend","isPartOf":{"@id":"https:\/\/pharma-trend.com\/en\/#website"},"primaryImageOfPage":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#primaryimage"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#primaryimage"},"thumbnailUrl":"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg","datePublished":"2023-01-03T16:02:08+00:00","breadcrumb":{"@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#breadcrumb"},"inLanguage":"en-US","potentialAction":[{"@type":"ReadAction","target":["https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/"]}]},{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#primaryimage","url":"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg","contentUrl":"https:\/\/mms.businesswire.com\/media\/20230103005566\/en\/1675341\/21\/logo.jpg"},{"@type":"BreadcrumbList","@id":"https:\/\/pharma-trend.com\/en\/global-oncology-biosimilars-market-report-2022-to-2027-industry-trends-share-size-growth-opportunities-and-forecasts-researchandmarkets-com\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Startseite","item":"https:\/\/pharma-trend.com\/en\/"},{"@type":"ListItem","position":2,"name":"Global Oncology Biosimilars Market Report 2022 to 2027: Industry Trends, Share, Size, Growth, Opportunities and Forecasts &#8211; ResearchAndMarkets.com"}]},{"@type":"WebSite","@id":"https:\/\/pharma-trend.com\/en\/#website","url":"https:\/\/pharma-trend.com\/en\/","name":"Pharma Trend","description":"","publisher":{"@id":"https:\/\/pharma-trend.com\/en\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/pharma-trend.com\/en\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"en-US"},{"@type":"Organization","@id":"https:\/\/pharma-trend.com\/en\/#organization","name":"Pharma Trend","url":"https:\/\/pharma-trend.com\/en\/","logo":{"@type":"ImageObject","inLanguage":"en-US","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/","url":"","contentUrl":"","caption":"Pharma Trend"},"image":{"@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/logo\/image\/"}},{"@type":"Person","@id":"https:\/\/pharma-trend.com\/en\/#\/schema\/person\/02d41342c7a74fa7f0032bb35ef0bb24","name":"Business Wire"}]}},"_links":{"self":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52478","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/users\/4"}],"replies":[{"embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/comments?post=52478"}],"version-history":[{"count":0,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/posts\/52478\/revisions"}],"wp:attachment":[{"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/media?parent=52478"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/categories?post=52478"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/pharma-trend.com\/en\/wp-json\/wp\/v2\/tags?post=52478"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}